Uniphos Enterprises Share Price
Sector: Chemical Manufacturing
You have to be logged in to add this to Watchlist.
Login or Register
153.50 -1.55 (-1.00%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
153.00
Today’s High
158.00
52 Week Low
123.10
52 Week High
196.00
153.00 -2.48 (-1.60%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
152.96
Today’s High
157.64
52 Week Low
129.44
52 Week High
195.50
Key Metrics
- Market Cap (In Cr) 1061.37
- Beta 0.97
- Div. Yield (%) 3.67
- P/B 0.52
- TTM P/E 878.98
- Peg Ratio 52.83
- Sector P/E 0
- Open Price 157.45
- Prev Close 155.05
Uniphos Enterprises Analysis
Price Analysis
-
1 Week0.92%
-
3 Months-8.44%
-
6 Month1.28%
-
YTD-1.12%
-
1 Year3.45%
Risk Meter
- 45% Low risk
- 45% Moderate risk
- 45% Balanced Risk
- 45% High risk
- 45% Extreme risk
Uniphos Enterprises Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 50.65
- Selling/ General/ Admin Expenses Total
- 3.18
- Other Operating Expenses Total
- 0.01
- Total Operating Expense
- 54.57
- Operating Income
- -3.92
- Net Income Before Taxes
- 38.94
- Net Income
- 38.61
- Diluted Normalized EPS
- 5.55
- Period
- 2024
- Total Assets
- 2077.5
- Total Liabilities
- 2.05
- Total Equity
- 2075.45
- Tangible Book Valueper Share Common Eq
- 298.43
- Period
- 2024
- Cashfrom Operating Activities
- -3.47
- Cashfrom Investing Activities
- 50.16
- Cashfrom Financing Activities
- -45.2
- Net Changein Cash
- 1.49
- Period
- 2023
- Total Revenue
- 1.47
- Selling/ General/ Admin Expenses Total
- 2.87
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0
- Total Operating Expense
- 4.94
- Operating Income
- -3.47
- Net Income Before Taxes
- 39.62
- Net Income
- 39.23
- Diluted Normalized EPS
- 5.64
- Period
- 2023
- Total Assets
- 3095.47
- Total Liabilities
- 97.87
- Total Equity
- 2997.6
- Tangible Book Valueper Share Common Eq
- 431.02
- Period
- 2023
- Cashfrom Operating Activities
- -1.47
- Cashfrom Investing Activities
- 40.63
- Cashfrom Financing Activities
- -39.29
- Net Changein Cash
- -0.13
- Period
- 2022
- Total Revenue
- 1.22
- Selling/ General/ Admin Expenses Total
- 3.11
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.03
- Total Operating Expense
- 4.38
- Operating Income
- -3.16
- Net Income Before Taxes
- 53.94
- Net Income
- 54.6
- Diluted Normalized EPS
- 7.85
- Period
- 2022
- Total Assets
- 3301.57
- Total Liabilities
- 121.04
- Total Equity
- 3180.53
- Tangible Book Valueper Share Common Eq
- 457.33
- Period
- 2022
- Cashfrom Operating Activities
- 0.52
- Cashfrom Investing Activities
- 20.43
- Cashfrom Financing Activities
- -23.65
- Net Changein Cash
- -2.69
- Period
- 2021
- Total Revenue
- 0.83
- Selling/ General/ Admin Expenses Total
- 3.07
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.01
- Total Operating Expense
- 3.93
- Operating Income
- -3.1
- Net Income Before Taxes
- 23.4
- Net Income
- 24.45
- Diluted Normalized EPS
- 3.52
- Period
- 2021
- Total Assets
- 2771.61
- Total Liabilities
- 56.9
- Total Equity
- 2714.71
- Tangible Book Valueper Share Common Eq
- 390.35
- Period
- 2021
- Cashfrom Operating Activities
- -4.59
- Cashfrom Investing Activities
- -33.86
- Net Changein Cash
- -38.45
- Period
- 2020
- Total Revenue
- 0.23
- Selling/ General/ Admin Expenses Total
- 2.27
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0
- Total Operating Expense
- 2.53
- Operating Income
- -2.31
- Net Income Before Taxes
- 20.43
- Net Income
- 20.07
- Diluted Normalized EPS
- 2.89
- Period
- 2020
- Total Assets
- 1518.52
- Total Liabilities
- 0.71
- Total Equity
- 1517.81
- Tangible Book Valueper Share Common Eq
- 218.25
- Period
- 2020
- Cashfrom Operating Activities
- -2.11
- Cashfrom Investing Activities
- 44.19
- Net Changein Cash
- 42.09
- Period
- 2019
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 2.79
- Depreciation/ Amortization
- 0
- Other Operating Expenses Total
- 0.02
- Total Operating Expense
- 2.85
- Operating Income
- -2.85
- Net Income Before Taxes
- 21.18
- Net Income
- 20.76
- Diluted Normalized EPS
- 2.99
- Period
- 2019
- Total Assets
- 2697.82
- Total Liabilities
- 0.18
- Total Equity
- 2697.64
- Tangible Book Valueper Share Common Eq
- 387.89
- Period
- 2019
- Cashfrom Operating Activities
- -3.21
- Cashfrom Investing Activities
- -1.94
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- -5.16
- Period
- 2018
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 1.93
- Depreciation/ Amortization
- 0.01
- Other Operating Expenses Total
- 0.02
- Total Operating Expense
- 2
- Operating Income
- -2
- Net Income Before Taxes
- 18.04
- Net Income
- 17.69
- Diluted Normalized EPS
- 2.54
- Period
- 2018
- Total Assets
- 2090.04
- Total Liabilities
- 0.16
- Total Equity
- 2089.87
- Tangible Book Valueper Share Common Eq
- 300.5
- Period
- 2018
- Cashfrom Operating Activities
- -3.37
- Cashfrom Investing Activities
- 8.69
- Cashfrom Financing Activities
- 0
- Net Changein Cash
- 5.32
- Period
- 2024-12-31
- Total Revenue
- 5.1
- Selling/ General/ Admin Expenses Total
- 0.57
- Depreciation/ Amortization
- 0.19
- Other Operating Expenses Total
- 0.48
- Total Operating Expense
- 6.29
- Operating Income
- -1.19
- Net Income Before Taxes
- -1.91
- Net Income
- -1.86
- Diluted Normalized EPS
- -0.27
- Period
- 2024-12-31
- Period
- 2024-12-31
- Period
- 2024-09-30
- Total Revenue
- 30.48
- Selling/ General/ Admin Expenses Total
- 0.39
- Depreciation/ Amortization
- 0.19
- Other Operating Expenses Total
- 0.38
- Total Operating Expense
- 31.15
- Operating Income
- -0.67
- Net Income Before Taxes
- 3.86
- Net Income
- 3.86
- Diluted Normalized EPS
- 0.56
- Period
- 2024-09-30
- Total Assets
- 2694.36
- Total Liabilities
- 116.56
- Total Equity
- 2577.81
- Tangible Book Valueper Share Common Eq
- 370.66
- Period
- 2024-09-30
- Cashfrom Operating Activities
- -1.62
- Cashfrom Investing Activities
- 10.53
- Cashfrom Financing Activities
- 0.22
- Net Changein Cash
- 9.12
- Period
- 2024-06-30
- Total Revenue
- 3.03
- Selling/ General/ Admin Expenses Total
- 0.41
- Depreciation/ Amortization
- 0.19
- Other Operating Expenses Total
- 0.38
- Total Operating Expense
- 3.97
- Operating Income
- -0.94
- Net Income Before Taxes
- -0.15
- Net Income
- -0.15
- Diluted Normalized EPS
- -0.02
- Period
- 2024-06-30
- Period
- 2024-06-30
- Period
- 2024-03-31
- Total Revenue
- 50.65
- Selling/ General/ Admin Expenses Total
- 0.9
- Depreciation/ Amortization
- 0.21
- Other Operating Expenses Total
- 0.06
- Total Operating Expense
- 51.71
- Operating Income
- -1.07
- Net Income Before Taxes
- -0.42
- Net Income
- -0.63
- Diluted Normalized EPS
- -0.09
- Period
- 2024-03-31
- Total Assets
- 2077.5
- Total Liabilities
- 2.05
- Total Equity
- 2075.45
- Tangible Book Valueper Share Common Eq
- 298.43
- Period
- 2024-03-31
- Cashfrom Operating Activities
- -3.47
- Cashfrom Investing Activities
- 50.16
- Cashfrom Financing Activities
- -45.2
- Net Changein Cash
- 1.49
- Period
- 2023-12-31
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.64
- Depreciation/ Amortization
- 0.21
- Other Operating Expenses Total
- 0.31
- Total Operating Expense
- 1.16
- Operating Income
- -1.16
- Net Income Before Taxes
- -0.03
- Net Income
- -0.03
- Diluted Normalized EPS
- 0
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.69
- Depreciation/ Amortization
- 0.21
- Other Operating Expenses Total
- 0.41
- Total Operating Expense
- 1.31
- Operating Income
- -1.31
- Net Income Before Taxes
- 39.48
- Net Income
- 39.36
- Diluted Normalized EPS
- 5.66
- Period
- 2023-09-30
- Total Assets
- 2689.88
- Total Liabilities
- 52.39
- Total Equity
- 2637.49
- Tangible Book Valueper Share Common Eq
- 379.24
- Period
- 2023-09-30
- Cashfrom Operating Activities
- -1.88
- Cashfrom Investing Activities
- 46.26
- Cashfrom Financing Activities
- -45.2
- Net Changein Cash
- -0.83
- Period
- 2023-06-30
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.72
- Depreciation/ Amortization
- 0.21
- Other Operating Expenses Total
- 0.41
- Total Operating Expense
- 1.33
- Operating Income
- -1.33
- Net Income Before Taxes
- -0.08
- Net Income
- -0.08
- Diluted Normalized EPS
- -0.01
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.66
- Depreciation/ Amortization
- 0.22
- Other Operating Expenses Total
- 0.07
- Total Operating Expense
- 0.95
- Operating Income
- -0.95
- Net Income Before Taxes
- 0.2
- Net Income
- 0.47
- Diluted Normalized EPS
- 0.07
- Period
- 2023-03-31
- Total Assets
- 3095.47
- Total Liabilities
- 97.87
- Total Equity
- 2997.6
- Tangible Book Valueper Share Common Eq
- 431.02
- Period
- 2023-03-31
- Cashfrom Operating Activities
- -1.47
- Cashfrom Investing Activities
- 40.63
- Cashfrom Financing Activities
- -39.29
- Net Changein Cash
- -0.13
- Period
- 2022-12-31
- Total Revenue
- 0
- Selling/ General/ Admin Expenses Total
- 0.61
- Depreciation/ Amortization
- 0.22
- Other Operating Expenses Total
- 0.53
- Total Operating Expense
- 1.36
- Operating Income
- -1.36
- Net Income Before Taxes
- -0.06
- Net Income
- -0.67
- Diluted Normalized EPS
- -0.1
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Uniphos Enterprises Technical
Moving Average
SMA
- 5 Day157.9
- 10 Day158.41
- 20 Day155.47
- 50 Day149.49
- 100 Day154.1
- 300 Day159.83
Uniphos Enterprises Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Chemfab Alkalis
- 786.05
- -13.75
- -1.72
- 1229.5
- 502
- 1118.43
- Amines & Plasticizers
- 196.5
- -5.5
- -2.72
- 359
- 178.6
- 1081.14
- Uniphos Enterprises
- 153.5
- -1.55
- -1
- 196
- 123.1
- 1061.37
- Tgv Sraac
- 98.54
- -2.61
- -2.58
- 120.9
- 74.19
- 1049.66
- Fairchem Organics
- 786.95
- -17.35
- -2.16
- 1552
- 775.25
- 1024.68
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Chemfab Alkalis
- 42.56
- 2.87
- 9
- 10.41
- Amines & Plasticizers
- 27.86
- 5.04
- 19.3
- 5.43
- Uniphos Enterprises
- 28.27
- 0.53
- 1.38
- 325.3
- Tgv Sraac
- 36.35
- 0.99
- 17.06
- 8.53
- Fairchem Organics
- 26.21
- 3.66
- -
- -
Uniphos Enterprises Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 13-Feb-25
- Quarterly Results
- 14-Nov-24
- Quarterly Results
- 13-Aug-24
- Quarterly Results
- 28-May-24
- Audited Results & Dividend
- 13-Feb-24
- Quarterly Results
- 08-Nov-23
- Quarterly Results
- 09-Aug-23
- Quarterly Results
- 26-May-23
- Audited Results & Dividend
- 14-Feb-23
- Quarterly Results
- 14-Nov-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 09-May-25
- 16-Apr-25
- EGM
- 20-Sept-24
- 27-Aug-24
- AGM
- 25-Aug-23
- 27-Jul-23
- AGM
- 07-Mar-22
- 09-Feb-22
- EGM
- 13-Aug-21
- 16-Jul-21
- AGM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 28-May-24
- -
- 06-Sept-24
- 5.7
- 26-May-23
- -
- 11-Aug-23
- 6.5
- 24-May-22
- -
- 04-Aug-22
- 5.65
- 26-May-21
- -
- 29-Jul-21
- 3.4
